ClinicalTrials.gov
ClinicalTrials.gov Menu

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease (CHARM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00077779
Recruitment Status : Completed
First Posted : February 16, 2004
Last Update Posted : September 26, 2007
Sponsor:
Information provided by:
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):